Transformation of endocardial endothelial cells into invasive mesenchyme is a critical antecedent of cardiac cushion tissue formation. The message for bone morphogenetic protein (BMP)-2 is known to be expressed in myocardial cells in a manner consistent with the segmental pattern of cushion formation [Development 109(1990) 833]. In the present work, we localized BMP-2 protein in atrioventricular (AV) myocardium in mice at embryonic day (ED) 8.5 (12 somite stage) before the onset of AV mesenchymal cell formation at ED 9.5. BMP-2 protein expression was absent from ventricular myocardium throughout the stages examined. After cellularization of the AV cushion at ED 10.5, myocardial BMP-2 protein expression was diminished in AV myocardium, whereas cushion mesenchymal cells started expressing BMP protein. Expression of BMP-2 in cushion mesenchyme persisted during later stages of development, ED 13.5 -16, during valuvulogenesis. Intense expression of BMP-2 persisted in the valve tissue in adult mice. Based on the expression pattern, we performed a series of experiments to test the hypothesis that BMP-2 mediates myocardial regulation of cardiac cushion tissue formation in mice. When BMP-2 protein was added to the 16 -18 somite stage (ED 9.25) AV endocardial endothelium in culture, cushion mesenchymal cells were formed in the absence of AV myocardium, which invaded into collagen gels and expressed the mesenchymal marker, smooth muscle (SM) a-actin; whereas the endothelial marker, PECAM-1, was lost from the invaded cells. In contrast, when noggin, a specific antagonist to BMPs, was applied together with BMP-2 to the culture medium, AV endothelial cells remained as an epithelial monolayer with little expression of SM a-actin, and expression of PECAM-1 was retained in the endocardial cells. When noggin was added to AV endothelial cells cocultured with associated myocardium, it blocked endothelial transformation to mesenchyme. AV endothelium treated with BMP-2 expressed elevated levels of TGFh-2 in the absence of myocardium, as observed in the endothelium cocultured with myocardium. BMP-2-supported elevation of TGFh-2 expression in endocardial cells was abolished by noggin treatment. These data indicated that BMP signaling is required in and BMP-2 is sufficient for myocardial segmental regulation of AV endocardial cushion mesenchymal cell formation in mice.
Introduction
Valvuloseptal morphogenesis of the primitive heart tube into a four-chambered organ requires the formation of endocardial cushion tissue in two segments of the primary heart tube, the atrioventricular (AV) canal, and conus/truncus outlet (OT). In each segment, transformation of endocardial endothelial cells into invasive mesenchyme is a critical antecedent of cardiac cushion tissue formation (Eisenberg and Markwald, 1995; Kisanuki et al., 2001; Markwald et al., 1975 Markwald et al., , 1977 . This transformation correlates spatially and temporally with the mRNA expression of bone morphogenetic protein (BMP)-2 and -4 in AV and OT myocardium (Lyons et al., 1990; Jones et al., 1991; Yamada et al., 1999; Yamagishi et al., 1999) . BMPs, a subgroup of the transforming growth factor (TGF)-h superfamily, are well implicated in embryonic development (Branford et al., 2000; Francis-West et al., 1994; Hogan, 1996; Wall and Hogan, 1995) . By using an in vitro culture assay system with avian embryos, BMP-2 was implicated as a cofactor in AV cushion morphogenesis, that is, functional synergy with TGFh-3 in AV epithelial -mesenchymal (E -M) transformation (Yamagishi et al., 1999) and involvement of the later phase of E -M transformation in chick (Romano and Runyan, 2000) . However, a recent paper documented interspecies differences in molecular requirements between chicks and mice for cultured endocardial cushion explants in AV canal morphogenesis (Camenisch et al., 2002) . Regarding mammalian development, BMP-2-deficient mouse embryos exhibit a defect in cardiac development and early embryonic lethality (Zhang and Bradley, 1996) . However, because the BMP-2-deficient mice die on embryonic day (ED) 8.5 (Zhang and Bradley, 1996) and BMP receptor (BMPR)-1A-deficient (Mishina et al., 1995) and BMP-4-deficient (Lawson et al., 1999) mice die up to ED 9.5, which is earlier than cardiac cushion tissue formation, the role of BMPs was not clear in AV canal cushion mesenchymal cell formation in mice. Therefore, to specifically elucidate the functional role of BMP-2 during AV cushion formation in mammals, we first explored its protein expression pattern in developing mouse embryos. BMP-2 protein was localized in mouse AV canal myocardium at ED 8.5 before AV cushion tissue formation, which occurs at around ED 9.5. BMP-2 was not expressed in the endocardium. After cardiac cushion tissue formation at ED 10.5, BMP-2 protein expression was diminished in the AV myocardium and, instead, cushion mesenchyme expressed BMP-2 protein.
Based on the protein expression pattern of BMP-2 in mice, we sought to determine the role of BMP-2 during AV cushion tissue formation by using collagen gel culture assay for mouse embryos. In the present work, by using carefully staged 16 -18 somite stage (ED 9.25) mouse embryos, we found that (1) exogenously added BMP-2 protein alone induced invasive mesenchymal cell formation from AV endocardial epithelium of the ED 9.25 mouse in the absence of myocardium; (2) the BMP antagonist noggin blocked BMP-2-supported mesenchymal cell formation from AV endothelium; (3) noggin blocked myocardially supported mesenchymal cell formation from AV endothelial cells; (4) up-regulation of cardiac cushion mesenchymal cell formation marker, smooth muscle (SM) a-actin, and down-regulation of the expression of the endothelial marker, PECAM-1, were detected in BMP-2-treated endocardial cells in the absence of myocardium; (5) noggin blocked expression of SM-a actin and downregulation of PECAM-1 in endocardial epithelial cells when treated with BMP-2 or cocultured with myocardium; and (6) TGFh-2 expression was promoted in the endocardial cells when treated with BMP-2 as well as cocultured with AV myocardium. The promotion of TGFh-2 expression was inhibited when noggin was added to the culture. Our findings lead us to conclude that the BMP pathway is required in and BMP-2 is sufficient for E -M transformation during AV cushion mesenchymal cell formation in mice.
This work was partially reported in an abstract form (Sugi et al., 1999) .
Materials and methods

Animals
C57BL/6 mice were kept at 23jC in a 12:12-h light/dark cycle and allowed free access to water and a standard pellet diet. Females were placed together with a male for 12 h, and mating was confirmed by the presence of a vaginal sperm plug. Pregnant mice were sacrificed by cervical dislocation and a cesarean section was performed. Embryos were collected in Earl's-buffered saline (EBSS), and somite number was counted to accurately determine the stages. ED 9.25 embryos with 16 -18 somites were used for the collagen gel assay.
Immunohistochemical localization of BMP-2 in mouse embryos
Anti-BMP-2 monoclonal antibody was kindly provided by Genetics Institute (Boston, MA). It is a monoclonal antibody raised against human BMP-2. Mouse BMP-2 has 87% homology with corresponding human sequences. Specificity of anti-BMP-2 was tested by indirect ELISA by the manufacturer. The antibodies used for this study react with BMP-2 and are not cross-reactive with other BMPs 3-7. In the present study, specificity of BMP-2 in immunostaining of the mouse embryonic tissue was verified by immunoabsorption. Anti-BMP-2 antibody was diluted to 1:500 (final concentration of IgG was 2.7 Ag/ml) and preabsorbed with 270 Ag/ml recombinant human BMP-2 (Genetics Institute) for 30 min at room temperature, followed by clarification at 13,000 Â g. This treatment abolished antibody staining in mouse tissue sections (Fig. 1d) .
Mouse embryos from ED 8.5 to 16.5 were fixed in methanol at À20jC overnight. Adult mouse hearts were also collected and fixed in methanol at À20jC. Samples were embedded in low melting temperature (50 -54jC) paraffin, Paraplast X-TRA, to preserve antigenicity. Embedded samples were stored at À20jC until sectioned at 5 Am. Sections were deparaffinized with xylene and rehydrated in a decreasing ethanol series. After rinsing with distilled water and phosphate-buffered saline (PBS; pH 7.2), the sections were incubated at room temperature with 10% normal goat serum (ICN Pharmaceuticals, Aurora, OH) for 15 min to block nonspecific binding. Sections were then incubated with primary antibody, anti-BMP-2 (final concentration of IgG, 2.7 Ag/ml in 1% bovine serum albumin (BSA)-PBS/ 0.02% NaN 3 ), primary antibody preabsorbed with BMP-2 as described above, or normal mouse IgG (2.7 Ag/ml in 1% BSA-PBS/0.02% NaN 3 ) as a negative control in a humid chamber at 4jC overnight. After rinsing with 1% BSA/PBS, fluorescein isothyocianate (FITC)-labeled rabbit anti-goat IgG (ICN Pharmaceuticals) was applied for 1 h. After rinsing, sections were mounted in DABCO (Sigma, St. Louis, MO) in 90% glycerol/PBS. Immunostained sections were examined under a Zeiss Axioscope.
Three-dimensional reconstruction of BMP-2 expression
Three-dimensional (3D) images were reconstructed by the method previously described (Okagawa et al., 1995 (Okagawa et al., , 1996 . Briefly, serial sections of ED 8.5 embryonic hearts were observed under a Zeiss Axioscope and digital images were captured in a computer (Power Macintosh G3, Apple, Cupertino, CA). External contours of the heart and locations of BMP-2 immunoreactivity were digitized. Data on 3D images were reconstructed for further rotation and examination by NIH-image (W. Rasband, NIH, Bethesda, MD).
Collagen gel assay for cushion mesenchyme formation
The preparation of hydrated collagen gel was modified from Bernanke and Markwald (1982) and described previously (Yamamura et al., 1997) . AV regions of the hearts were dissected from the embryos. Each AV region was cut longitudinally to expose the lumen and placed on the drained collagen gels (1 mg/ml, type I rat-tail collagen) that had been saturated with the medium, OptiMEM (GibcoBRL, Grand Island, NY) supplemented with 1% heatinactivated fetal bovine serum (Hyclone, Logan, UT), ITS (5 Ag/ml insulin, 5 Ag/ml transferrin, 5 ng/ml selenium, Collaborative Research), and streptomycin/penicillin (GibcoBRL). Additional media were added to the cultures 2 h later and incubation was continued. For some explants, myocardium was removed after another additional 2 h of incubation. To assess the biological activity of BMP-2 during E -M transformation, AV explants (endocardialmyocardial coculture or endocardial culture without myocardium) were treated with control OptiMEM alone, BMP-2 (200 ng/ml), or BMP-2 (200 ng/ml) + noggin, an antagonist to BMPs (Zimmerman et al., 1996) (500 ng/ml). Recombinant human BMP-2 was a generous gift from Genetics Institute, Inc. (Cambridge, MA). Recombinant human nog- gin was kindly provided by Regeneron Pharmaceuticals, Inc. (Tarrytown, NY). Mesenchymal formation was assessed at 48 h by counting the number of invasive mesenchymal cells in the collagen gel with an inverted microscope equipped with Hoffman optics (Olympus, IMT-2). Culture was not considered to be mesenchymal unless greater than three mesenchymal cells were observed beneath the surface of the gel as previously described (Yamamura et al., 1997) .
Immunohistochemistry of collagen gel-cultured mouse AV explants AV explants were processed for whole-mount immunostaining. Cultured explants were drained of medium, rinsed with PBS, fixed with methanol at À20jC for 1 h, rinsed with PBS and blocked for 1 h with 10% normal goat serum (ICN, Cappel, Aurora, OH) with 1% BSA (Sigma) in PBS. After incubation at 4jC overnight with primary antibodies, anti-PECAM-1 (CD31) (Pharmingen, San Diego, CA), anti-SM a-actin (Sigma), or anti-TGFh-2 (Santa Cruz, CA), samples were rinsed and incubated with either tetramethylrhodamine isothiocyanate (TRITC) or FITC-conjugated secondary antibodies (ICN). Anti-PECAM-1, which was raised against mouse PECAM-1, was purchased from Pharmingen. PECAM-1 has been used as a mouse endothelial cell marker (Baldwin et al., 1994) . Anti-SM a-actin has been used as a mesenchymal marker for cardiac cushion cells in mice (Yamamura et al., 1997) and was purchased from Sigma. Anti-TGFh-2 was raised against a peptide corresponding to amino acids 352-377 mapping at the carboxyterminus of TGFh-2 of human origin, which has 90% homology with mouse TGFh-2. Anti-TGFh-2 reacts with TGFh-2 of mouse origin in Western blotting and immunoprecipitation and immunohistochemistry and is non-cross-reactive with either TGFh-1 or TGFh-3 by manufacturer (Santa Cruz Biotechnology, Santa Cruz, CA). In the present study, specificity of TGFh-2 in immunostaining of the mouse embryonic tissue was verified by immunoabsorption. Anti-TGFh-2 antibody was diluted to 1:100 (final concentration of IgG was 1 Ag/ ml) and preabsorbed with 100 Ag/ml immunogenic peptide (Santa Cruz Biotechnology) for 30 min at room temperature, Fig. 3 . AV endocardial monolayers from ED 9.25 (16 -18s) mice were treated with BMP-2 (a and b), BMP-2 + noggin (c and d), or control OptiMEM (e and f) in the absence of the myocardium; a, c, and e surface view; b, d, and f deep view in the collagen gels (À80 Am from the surface). AV endocardial monolayer treated with BMP-2 showed cell -cell separation (arrow heads in a) and invasive mesenchymal cell formation (arrowheads in b). Effect of BMP-2 was abolished when noggin was added to the medium and endocardial monolayer grew and extended on the surface of the gel (c and d). Endocardial monolayer cultured with control OptiMEM alone did not show E -M transformation (e and f).
followed by clarification at 13,000 Â g. This treatment abolished antibody staining in mouse AV cultures (not shown). Samples were rinsed, mounted with DABCO (Sigma), in 90% glycerol/PBS after an antiquench mounting medium, and observed under a fluorescent microscope (Leica, BMLB) or with confocal microscopy using a BioRad MRC-1000 Laser Scanning Confocal Imaging System.
TGFb-2 immunointensity in cultured endocardial cells
The original photo was taken under a Laser Scanning Confocal-Microscope (Bio-Rad MRC-1000) equipped with Zeiss Axioscope. For each sample, the same condenser iris opening (4.0) and 30% laser was applied. TGFh-2 immunointensity was evaluated by measuring the intensity of TGFh-2 immunofluorescence using the computer software, Adobe Photoshop 5.5 (Adobe Systems, Inc., San Jose, CA). Average fluorescence intensity of the cultured epithelial and mesenchymal cells was normalized by subtracting the fluorescence intensity in the background of each photo.
Results
Immunohistochemical localization of BMP-2 in AV cushion formation and subsequent valvulogenesis
Antibody localization of BMP-2 was performed in embryonic mouse hearts at ED 8.5 -16.0 and in adult hearts. The antibodies used for this study react with BMP-2 and are not cross-reactive with other BMPs 3-7 according to the manufacturer (Genetics Institute). The specificity of BMP-2 in immunostaining of the mouse embryonic tissue was verified by immunoabsorption (see details in Materials and methods). This treatment abolished BMP-2 antibody staining in mouse sections (Fig. 1d) . Intense cytoplasmic staining was detected in atrial, AV canal, and OT myocardium but not in the ventricular myocardium or endocardium at ED 8.5 (Figs. 1a and b) . Computer-aided three-dimensional reconstruction of the ED 8.5 mouse heart stained with BMP-2 antibodies clearly indicated that BMP protein expression was confined to dorsal wall of the atrium, AV canal, and OT but not in the ventricle (Fig. 2) . This expression pattern persisted up to ED 9.5 at the onset of AV cushion formation in mice, which provided the basis of Frequency-number of AV endocardium forming mesenchymal cells by 48 h. Mesenchymal cell formation was determined by observing more than three cells beneath the surface of the collagen gels. the experimental design to address the role of BMP-2 during AV valvulogenesis. After cushion mesenchymal cell formation occurred, BMP-2 expression was diminished in the myocardium of the AV canal and associated atrium. Instead, BMP-2 was clearly localized in the AV cushion mesenchymal cells (Fig. 1c) . When valvulogenesis proceeded to later stages, BMP-2 continued to be localized in mesenchymal cells in AV valvular mesenchyme and AV septum (Fig. 1e) .
However, in certain areas, valve tissue appeared to loose BMP-2 immunostaining during valvulogenesis. This may be explained by the fact that parts of valve mesenchyme may have been replaced by myocardial cells, which differentiated from mesenchymal cells during valvulogenesis (de la Cruz and Van den Hoff et al., 2000) . BMP-2 protein remained expressed in valve leaflets up to the adult stage (Fig. 1f) . BMP-2 induced cell -cell separation and invasive mesenchymal cell formation (E -M transformation) from AV endocardial endothelial cells in the absence of myocardium AV endocardial endothelium is composed of an epithelial monolayer at ED 9.25 (16 -18 somite stage). AV endocardial cushion transformation occurs between 21 and 28 somite stages (ED 9.5) in mice (Camenisch et al., 2002) . Because after the 20 -21 somite stage, transformation of endocardial epithelial cell to mesenchymal cell (E -M transformation) was often observed in our collagen gel culture assay system without any treatments, only mouse embryos with 16-18 somites were carefully selected for the AV E -M transformation assay. Under the condition of our mouse AV bioassay system, when cultured with control OptiMEM, the endocardial epithelial monolayer did not extend peripherally as seen in chick AV transformation assay but remained as an epithelial cells on the surface of the collagen gel (Figs. 3e and f, also see Yamamura et al., 1997) . When 200 ng/ml BMP-2 was added to the culture, cell-cell separation and subsequent invasive mesenchymal cell formation (E -M transformation) occurred within 48 h (Figs. 3a and b) . The same results were obtained when 100 ng/ml of BMP-2 was used in the culture assay (data not shown). Noggin blocked BMP-2-supported cell -cell separation and subsequent invasive mesenchymal cell formation in AV endocardial endothelial cells. In the presence of noggin, extended epithelial monolayers were consistently formed (Figs. 3c and d) . These experiments clearly indicate that noggin, an antagonist of BMP-2/4, blocked the effect of exogenously added BMP-2 in the E -M transformation assay in mouse AV explants. These data indicated that BMP-2 could induce E -M transformation from mouse AV endocardial endothelial cells.
Noggin inhibited cell -cell separation and invasive mesenchymal cell formation (E -M transformation) from AV endocardial endothelial cells cultured in the presence of myocardium AV endocardial endothelium from the 16 -18 somite stage (ED 9.25) mouse embryos formed invasive mesenchymal cells within 48 h when cocultured with associated myocardium in control OptiMEM (Figs. 4a and b) . Note that mouse AV endocardial endothelium, which was cocultured with myocardium, did not form a large epithelial monolayer as typically observed in chick AV explants (Figs. 4a and b, also see Yamamura et al., 1997) . When noggin was added to AV endocardial endothelium cocultured with associated myocardium, cell -cell separation and subsequent invasive mesenchymal cell formation (E -M transformation) were completely abolished and instead a large endocardial epithelial monolayer was formed on the surface of collagen gels (Figs. 4c and d) . These data evidenced that BMP signaling was required in AV E -M transformation supported by AV myocardium in mice. Table 1 summarizes results obtained from collagen gel culture assays.
Markers for E -M transformation affirmed invasive mesenchymal cell formation in AV explants
PECAM-1 has been known to be expressed in mouse endothelial cells but down-regulated during their E -M transformation in the AV canal (Baldwin et al., 1994) . Conversely, SM a-actin is expressed in invasive mesenchymal cells after complete E -M transformation but not in the endocardial epithelial cells in chick and mouse explants (Nakajima et al., 1997; Yamamura et al., 1997) . Therefore, expression of these two molecules was used as makers for further determining the characteristics of the cells, either endothelial or mesenchymal, in the present study. Expression of epithelial marker PECAM-1 was retained in the endocardial endothelial cells when AV endocardial epithelium was cultured with control OptiMEM alone or BMP-2 + noggin in the absence of myocardium (Figs. 5a and e) . Double immunohistochemistry of PECAM-1 and SM aactin demonstrated that the explants that expressed PECAM-1 in endothelial cells, which were treated with either OptiMEM alone or BMP-2 + noggin, did not express the mesenchymal marker, SM a-actin (Figs. 5b and f) . Conversely, SM a-actin was detected only in the explants that formed invasive mesenchymal cells, which were either treated with BMP-2 or cocultured with myocardium ( Figs.  5d and h ). The expression pattern of E -M transformation markers, PECAM-1 and SM a-actin, affirmed the results observed by Hoffman optics, in which BMP-2 as well as AV myocardium induced E -M transformation of AV endocardium in collagen gel-cultured mouse explants. Taken together, these data further supported our hypothesis that BMP-2 is a sufficient and essential inducer in E -M transformation supported by AV myocardium in mice.
BMP-2 as well as myocardium induced TGFb-2 expression in AV endocardial cells Elevated expression of TGFh-2 mRNA has been observed in mouse AV cushion mesenchyme coincident with E -M transformation in vivo (Camenisch et al., 2002; Molin et al., 2003) . A recent paper documented that TGFh-2 but not TGFh-3 was required in AV E -M transformation in mice (Camenisch et al., 2002) . Therefore, in this work, we sought to address the interaction of myocardially derived BMP-2 and endocardially expressed TGFh-2 on the AV E -M transformation in mice.
When AV endocardium was cultured in OptiMEM alone in the absence of the myocardium, all cells remained on the surface of the collagen gels and a weak punctate cytoplasmic expression of TGFh-2 was observed in endocardial epithelial cells (Figs. 6a and 7) . When AV endocardium was cultured in OptiMEM in the presence of associated AV myocardium, endocardial cells transformed into invasive mesenchymal cells and those cells exhibited a significant increase of TGFh-2 immunointensity in the cytoplasm (Figs. 6b and 7) . Similarly, increased TGFh-2 was detected in the invasive mesenchymal cells when endocardial endothelium was treated with BMP-2 in the absence of myocardium (Figs. 6c and 7) . Noggin blocked BMP-2 or myocardially supported increases in TGFh-2 expression in endocardial endothelial cells (Figs. 6d and e and 7) . These experimental data are summarized in Fig. 8 .
Discussion
Transformation of the AV canal endocardium into invasive mesenchyme called ''cushion tissue'' is a critical antecedent for valvuloseptal morphogenesis. Myocardially derived factors are implicated in the induction of the mesenchymal cell formation from AV endothelial explants (Eisenberg and Markwald, 1995; Krug et al., 1985 Krug et al., , 1987 Fig. 8 . Summary diagram showing the results of bioassay to assess the role of BMP-2 during epithelial -mesenchymal (E -M) transformation in mouse AV explants. Mouse embryos at ED 9.25 with 16 -18 somites were used for the collagen gel assay. Results were evaluated 48 h after the explantation. AV endocardial monolayer cultured with OptiMEM in the presence of the myocardium formed invasive mesenchymal cells, which expressed SM a-smooth muscle actin and TGFh-2 and lost PECAM-1. Noggin treatments inhibited myocardially supported invasive mesenchymal cell formation and mesenchymal markers, SM a-actin, and TGFh-2 expression. Endocardial monolayer remained on the surface of the collagen gels and retained PECAM-1 endothelial marker. Endocardial monolayer cultured with OptiMEM in the absence of myocardium did not transform and remained epithelial. When BMP-2 was added to this condition, invasive mesenchymal cell formation (E -M transformation) occurred. Noggin blocked BMP-2-supported E -M transformation. A: atrium; AV: atrioventricular canal; End: endocardium; Myo: myocardium; OT: outflow tract; *, weak dot-like immunostaining. Markwald et al., 1996; Mjaatvedt and Markwald, 1989; Mjaatvedt et al., 1987 Mjaatvedt et al., , 1991 . Specifically, myocardium in the AV canal but not in the ventricle has the potential to induce AV endocardial cells to transform into cushion mesenchymal cells Runyan and Markwald, 1983) . Messenger RNA for BMP-2 has been localized in the AV canal and OT but not in the ventricular myocardium in mouse (Abdelwahid et al., 2001; Lyons et al., 1990) and chick (Yamada et al., 1999; Yamagishi et al., 1999) hearts at the time coincident with the AV cushion formation. Our present work is the first study to explore the expression pattern of BMP-2 protein in developing mouse hearts including stages before and after AV cushion formation. BMP-2 protein was expressed in AV, OT, and atrial myocardium but not in the ventricle or endocardium in mouse hearts at ED 8.5 before AV cushion mesenchyme formation (Figs. 1 and 2 ). This expression pattern persisted up to ED 9.5, the onset of AV cushion formation. There were no fundamental differences in expression patterns between BMP-2 protein and its reported mRNA in developing mouse myocardium (Lyons et al., 1990) . In the present work, we found that BMP-2 protein expression was diminished in myocardium after the onset of AV E -M transformation whereas BMP-2 expression became evident in the cytoplasm of AV cushion mesenchymal cells, which remained positive throughout all stages of valvulogenesis including the adult stage.
By using well-established collagen gel culture assays for chick embryos, BMP-2 was previously implicated in AV cushion morphogenesis, that is, functional synergy with TGFh-3 in E -M transformation (Nakajima et al., 2000; Yamagishi et al., 1999) . Yamagishi et al. (1999) reported that BMP-2 promoted AV E -M transformation when BMP-2 was added together with TGFh-3 in a chick AV explant culture. However, our data suggested that BMP-2 alone can elicit AV E -M transformation in our mouse culture assay (Figs. 3 and 5) The apparent discrepancy might be derived from differences in species (mouse vs. chick) or differences in experimental designs and procedures. Distinct interspecies differences between mice and avian embryos were recently reported with respect to expression pattern and function of TGFh-2 and TGFh-3 during AV cushion tissue formation (Camenisch et al., 2002) . Data from Camenisch et al. (2002) indicated that TGFhs did not have the same ligand specificity in AV canal morphogenesis in mice as in chick embryos. Therefore, different molecular requirements for BMP-2 might explain why BMP appears more indispensable in mouse AV E -M transformation than it does in chick.
In our mouse AV explants assays, we carefully selected 16 -18 somite stage (ED 9.25) mouse embryos for transformation assays since E -M transformation occurs in AV endothelial cells from embryos older than the 20 -21 somite stage without any treatment or the presence of myocardium in the control medium (data not shown, also see Yamamura et al., 1997) . These data are consistent with the in vivo observation, which indicates that AV cushion formation occurs between 21 and 28 somites for mouse embryos (Camenisch et al., 2002) . Endocardial endothelial cells from 16 to 18 somite embryos do not transform in the control medium in the absence of the myocardium (Fig. 3 and Table  1 ). Therefore, it is unlikely that our findings were the result of the endocardium being preactivated before BMP-2 was exogenously added to the culture nor it is likely to be a dosage effect. For example, Yamagishi et al. (1999) used 1 Ag/ml for chick AV culture assays vs. 200 ng/ml we used for our mouse assays. We also observed the same biological response at 100 ng/ml BMP-2 in the mouse AV cushion formation assay (data not shown). BMP-2, as a member of the TGFh superfamily, is known to affect the biological responses in a dose-dependent manner. The dosage used in functional assays ranged from 50 (Lough et al., 1996) to 200 ng/ml (Schultheiss et al., 1997) in primary culture assays for heart formation from precardiac mesoderm, and an inhibitory reaction was observed with the higher dosage of BMP in heart formation assays (Ladd et al., 1998) . Thus, the higher levels of BMP-2 may have inhibited BMP-2 pathway resulting in the addition of TGFh-3 to complete the transformations.
Another discrepancy found between the present mouse data and chick experiments was related to the effects of noggin, an antagonist to BMPs in E -M transformation. In the chick AV culture assay, conditioned media from Chinese hamster ovary (CHO) cells stably expressing Xenopus noggin appeared to disrupt later steps of E -M transformation, that is, invasion of the cells into collagen gels but not the initial steps of E -M transformation, that is, cell -cell separation (Romano and Runyan, 2000) . Mouse endocardial cells do not normally form a large endocardial epithelial monolayer or display intermediate cell -cell separation before transformation, which is an obstacle in determining the functional role of exogenously added proteins on the initial steps of E -M transformation. However, because recombinant human noggin (500 ng/ml) caused a substantial outgrowth of endocardial cells on the gel surface without cellcell separation when endocardial epithelium was cultured with BMP-2 or associated AV myocardium (Figs. 3 and 4) , it is more likely that BMP-2 acted on a very early step of E -M transformation (cell -cell separation) rather than a later step of E-M transformation (invasive mesenchymal cell formation) in mice.
In our mouse AV explant culture assays, recombinant human noggin was applied at a final concentration of 500 ng/ml, which was sufficient to completely block E -M transformation. However, this might not have been the case in a recent experiment in which viruses were used to deliver noggin. Retrovirally supported noggin expression experiments in chick whole-embryo cultures caused abnormalities of the septum and a decrease in the number of proliferating mesenchymal cells of OT but, unlike our data, rarely produced defects in AV cushion formation (Allen et al., 2001) . Although chick embryonic hearts showed extensive viral infection after injection, it is possible that the virus did not infect 100% of AV myocardial cells, and therefore production of noggin may have been insufficient to completely block BMP pathways in the AV canal. This explanation is further supported by evidence that an inhibition of BMP-dependent events, such as the down-regulation of Msx1, occurred in mesenchymal cells in the OT but not in the AV canal mesenchyme after noggin virus infection.
TGFhs (Boyer et al., 1999a; Nakajima et al., 1994 Nakajima et al., , 1998 Potts and Runyan, 1989; Potts et al., 1991; Ramsdell and Markwald, 1997; Romano and Runyan, 2000) and their receptors (Brown et al., 1996 (Brown et al., , 1999 Boyer and Runyan, 2001; Boyer et al., 1999b; Lai et al., 2000) are the most well-documented factors implicated in AV cushion mesenchymal cell formation and migration. In chick embryos, endocardial epithelial cells, upon activation by myocardial signaling, appear to express TGFhs as part of an in vivo autocrine mechanism for regulating the transformation from epithelial to mesenchymal phenotype in AV endocardial cells (Nakajima et al., 1994 (Nakajima et al., , 1998 Ramsdell and Markwald, 1997) . In mouse, TGFh-2 has been localized in AV myocardium before AV transformation and in AV cushion mesenchyme after E -M transformation (Camenisch et al., 2002; Dickson et al., 1993; Molin et al., 2003) . In a recent publication, studies on AV endocardial morphogenesis in mice revealed that only TGFh-2 but not TGFh-3 was expressed at a time coincident with AV E -M transformation and was obligatory for endocardial cushion cell transformation (Camenisch et al., 2002) . Expression of TGFh-2 becomes enhanced in cushion mesenchyme during early AV cushion development in mice (Camenisch et al., 2002) . The observation that TGFh-2 is detected in the AV myocardium as well as in transformed mesenchymal cells suggests that TGFh-2 may have an autocrine function in addition to its paracrine pathway. Thus, up-regulation of TGFh-2 in endocardial cells may be a potent key step of AV E -M transformation in mice. Therefore, we sought to determine the interactions between BMP signaling and endocardially expressed TGFh-2 during AV E -M transformation. In our present mouse data, BMP-2, as well as cocultured AV myocardium, promoted expression of TGFh-2 in endocardial cells coincident with E -M transformation. Noggin inhibited an increase of TGFh-2 expression in AV endocardial cells and E -M transformation in the presence of associated AV myocardium or exogenously added BMP-2 (Figs. 6 and 7) . These data indicate that myocardially derived BMP-2 can regulate TGFh-2 expression in AV endocardium and E -M transformation.
There may be several possible signaling pathways related to the up-regulation of endocardial TGFh-2. For example, myocardially derived BMP-2 might directly regulate TGFh-2 expression in the endocardium in the AV canal through a paracrine pathway or myocardial BMP-2 could induce TGFh-2 or other regulatory molecules in the AV myocardium through autocrine pathways, which subsequently regulated endocardial expression of TGFh-2. The latter possibility is supported by the recent data that conditional deletion of the BMP receptor-1A (ALK3) from the myocardium in mice exhibited a decrease in TGFh-2 in the myocardium adjacent to the AV canal (Gaussin et al., 2002) . In these mutant mice, an autocrine loop of BMP-2 in the myocardium was supposed to be blocked by the deletion of the BMP receptor in the myocardium. This conditional deletion caused defects in the fusion of AV cushions and formation of the interventricular septum and trabeculae. However, in the mutant mice, E -M transformation did occur, presumably because myocardial BMP-2 or some other secreted proteins directly affected AV endocardium through a paracrine pathway for E -M transformation. Our data from the in vitro culture assay and the genetic deletion data from Gaussin et al. (2002) both suggest that TGFh-2 is a potential downstream target of BMP signaling in AV cushion formation in mice. Taken together, our mouse data suggest that BMP-2 is a part of myocardially derived paracrine signaling pathway to potentially induce autocrine pathways of TGFh-2 in target AV endocardial cells followed by their transformation into cushion mesenchymal cells. Since BMP-2 is expressed in transformed cushion mesenchyme and expression is sustained up to the later valvulogenesis stage, it might be of interest to determine if the expression of BMP-2 is related to later morphologic events during mouse AV morphogenesis.
